857 related articles for article (PubMed ID: 33933722)
1. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study.
Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722
[TBL] [Abstract][Full Text] [Related]
2. Sex-specific responses in glucose-insulin homeostasis and lipoprotein-lipid components after high-dose supplementation with marine n-3 PUFAs in abdominal obesity: a randomized double-blind crossover study.
Laupsa-Borge J; Grytten E; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
Front Nutr; 2023; 10():1020678. PubMed ID: 37404855
[TBL] [Abstract][Full Text] [Related]
3. Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia.
Skulas-Ray AC; Alaupovic P; Kris-Etherton PM; West SG
J Clin Lipidol; 2015; 9(3):360-7. PubMed ID: 26073395
[TBL] [Abstract][Full Text] [Related]
4. Use of manufactured foods enriched with fish oils as a means of increasing long-chain n-3 polyunsaturated fatty acid intake.
Lovegrove JA; Brooks CN; Murphy MC; Gould BJ; Williams CM
Br J Nutr; 1997 Aug; 78(2):223-36. PubMed ID: 9301413
[TBL] [Abstract][Full Text] [Related]
5. A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.
Allaire J; Couture P; Leclerc M; Charest A; Marin J; Lépine MC; Talbot D; Tchernof A; Lamarche B
Am J Clin Nutr; 2016 Aug; 104(2):280-7. PubMed ID: 27281302
[TBL] [Abstract][Full Text] [Related]
6. Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects.
Finnegan YE; Minihane AM; Leigh-Firbank EC; Kew S; Meijer GW; Muggli R; Calder PC; Williams CM
Am J Clin Nutr; 2003 Apr; 77(4):783-95. PubMed ID: 12663273
[TBL] [Abstract][Full Text] [Related]
7. Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholid and apolipoprotein B concentrations in young adult women.
Sanchez-Muniz FJ; Bastida S; Viejo JM; Terpstra AH
Eur J Nutr; 1999 Feb; 38(1):20-7. PubMed ID: 10338684
[TBL] [Abstract][Full Text] [Related]
8. Substitution of dietary ω-6 polyunsaturated fatty acids for saturated fatty acids decreases LDL apolipoprotein B-100 production rate in men with dyslipidemia associated with insulin resistance: a randomized controlled trial.
Drouin-Chartier JP; Tremblay AJ; Lépine MC; Lemelin V; Lamarche B; Couture P
Am J Clin Nutr; 2018 Jan; 107(1):26-34. PubMed ID: 29381796
[TBL] [Abstract][Full Text] [Related]
9. N-3 fatty acid supplementation mediates lipid profile, including small dense LDL, when combined with statins: a randomized double blind placebo controlled trial.
Dogay Us G; Mushtaq S
Lipids Health Dis; 2022 Sep; 21(1):84. PubMed ID: 36050695
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
11. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
[TBL] [Abstract][Full Text] [Related]
12. Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial.
Asztalos IB; Gleason JA; Sever S; Gedik R; Asztalos BF; Horvath KV; Dansinger ML; Lamon-Fava S; Schaefer EJ
Metabolism; 2016 Nov; 65(11):1636-1645. PubMed ID: 27733252
[TBL] [Abstract][Full Text] [Related]
13. A Randomized Trial of ω-3 Fatty Acid Supplementation and Circulating Lipoprotein Subclasses in Healthy Older Adults.
Moosavi D; Vuckovic I; Kunz HE; Lanza IR
J Nutr; 2022 Jul; 152(7):1675-1689. PubMed ID: 35389487
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.
Yee LD; Lester JL; Cole RM; Richardson JR; Hsu JC; Li Y; Lehman A; Belury MA; Clinton SK
Am J Clin Nutr; 2010 May; 91(5):1185-94. PubMed ID: 20335550
[TBL] [Abstract][Full Text] [Related]
15. Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study.
Caslake MJ; Miles EA; Kofler BM; Lietz G; Curtis P; Armah CK; Kimber AC; Grew JP; Farrell L; Stannard J; Napper FL; Sala-Vila A; West AL; Mathers JC; Packard C; Williams CM; Calder PC; Minihane AM
Am J Clin Nutr; 2008 Sep; 88(3):618-29. PubMed ID: 18779276
[TBL] [Abstract][Full Text] [Related]
16. Effects of modest doses of omega-3 fatty acids on lipids and lipoproteins in hypertriglyceridemic subjects. A randomized controlled trial.
Deck C; Radack K
Arch Intern Med; 1989 Aug; 149(8):1857-62. PubMed ID: 2669667
[TBL] [Abstract][Full Text] [Related]
17. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
[TBL] [Abstract][Full Text] [Related]
18. Oily fish reduces plasma triacylglycerols: a primary prevention study in overweight men and women.
Moore CS; Bryant SP; Mishra GD; Krebs JD; Browning LM; Miller GJ; Jebb SA
Nutrition; 2006 Oct; 22(10):1012-24. PubMed ID: 17027436
[TBL] [Abstract][Full Text] [Related]
19. Plasma fatty acid changes following consumption of dietary oils containing n-3, n-6, and n-9 fatty acids at different proportions: preliminary findings of the Canola Oil Multicenter Intervention Trial (COMIT).
Senanayake VK; Pu S; Jenkins DA; Lamarche B; Kris-Etherton PM; West SG; Fleming JA; Liu X; McCrea CE; Jones PJ
Trials; 2014 Apr; 15():136. PubMed ID: 24754911
[TBL] [Abstract][Full Text] [Related]
20. Postprandial effect of n-3 polyunsaturated fatty acids on apolipoprotein B-containing lipoproteins and vascular reactivity in type 2 diabetes.
Hilpert KF; West SG; Kris-Etherton PM; Hecker KD; Simpson NM; Alaupovic P
Am J Clin Nutr; 2007 Feb; 85(2):369-76. PubMed ID: 17284731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
